ResearcherYonsei UniversityNo recent work listed
Young‐Joo Won
Matched on ORCID iD 0000-0001-9861-6740; OpenAlex author ID A5027936126. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2022: 2 papers · 2023: 1 paper
Papers 3
- Exocrine pancreatic cancer as a second primary malignancy: A population-based study. Last author DOI 10.14701/ahbps.23-053↗
- Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea. First author DOI 10.3346/jkms.2022.37.e216↗
- First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017. Co-author DOI 10.4143/crt.2021.421↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sung‐Sik Han · 3 shared papers, 2022–2023 · strength 0.54
- Paper Exocrine pancreatic cancer as a second primary malignancy: A population-based study. DOI 10.14701/ahbps.23-053↗
- Paper Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea. DOI 10.3346/jkms.2022.37.e216↗
- Paper First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017. DOI 10.4143/crt.2021.421↗
- Hyeong Min Park · 3 shared papers, 2022–2023 · strength 0.54
- Paper Exocrine pancreatic cancer as a second primary malignancy: A population-based study. DOI 10.14701/ahbps.23-053↗
- Paper Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea. DOI 10.3346/jkms.2022.37.e216↗
- Paper First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017. DOI 10.4143/crt.2021.421↗
- Mee Joo Kang · 3 shared papers, 2022–2023 · strength 0.54
- Paper Exocrine pancreatic cancer as a second primary malignancy: A population-based study. DOI 10.14701/ahbps.23-053↗
- Paper Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea. DOI 10.3346/jkms.2022.37.e216↗
- Paper First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017. DOI 10.4143/crt.2021.421↗
- Sun‐Whe Kim · 3 shared papers, 2022–2023 · strength 0.54
- Paper Exocrine pancreatic cancer as a second primary malignancy: A population-based study. DOI 10.14701/ahbps.23-053↗
- Paper Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea. DOI 10.3346/jkms.2022.37.e216↗
- Paper First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017. DOI 10.4143/crt.2021.421↗
- Sang‐Jae Park · 3 shared papers, 2022–2023 · strength 0.54
- Paper Exocrine pancreatic cancer as a second primary malignancy: A population-based study. DOI 10.14701/ahbps.23-053↗
- Paper Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea. DOI 10.3346/jkms.2022.37.e216↗
- Paper First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017. DOI 10.4143/crt.2021.421↗
- Kyu‐Won Jung · 1 shared paper, 2022 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.